Pieter Cullis
(University of British Columbia)
10/06/2025, 09:00
Herzberg Public and Plenary Talks / Conférenciers des sessions Herzberg et plénières
Plenary Speaker / Conférencier(ère) plénier(ère)
Delivery of nucleic acid-based drugs into target cells in vivo has been a major challenge for enabling gene therapies. This barrier is now being overcome due in part to advances made in lipid nanoparticle (LNP) delivery systems. LNP systems enable the mRNA COVID-19 vaccines and there are a host of LNP RNA vaccines and therapeutics in clinical development. Advantages of LNP RNA systems over...
